Head, Throat Cancer Survival May Be Longer if Tumor Caused by HPV: Study

THURSDAY, Feb. 20, 2014 (HealthDay News) -- Patients with
recurrent mouth and throat cancers are more likely to survive if
the tumors are caused by the human papillomavirus (HPV) and not
smoking, according to new research.

"Until this study, we thought that once these cancers came back, patients did equally poorly regardless of whether their disease was linked to HPV," said study leader Dr. Carole Fakhry, an assistant professor in the department of otolaryngology at the Johns Hopkins University School of Medicine.

"Now we know that once they recur, HPV status still matters," Fakhry said in a university news release. "They still do better."

The study included nearly 200 patients with late-stage mouth or
throat cancer who had undergone successful chemotherapy and
radiation treatment. Of those patients, 58 percent had cancers
caused by HPV and 42 percent had cancers triggered by smoking or
other causes.

The median time between the end of treatment and the
reappearance of cancer was similar -- a little more than eight
months for those with HPV-positive cancers and about seven months
for those with HPV-negative cancers.

But about 55 percent of patients with HPV-positive cancers were
alive two years after recurrence, compared with 28 percent of those
with HPV-negative cancers, according to the study.

The researchers also found that patients whose recurrent cancer
could be treated with surgery -- regardless of whether it was
HPV-related or not -- were 52 percent less likely to die than those
who did not have surgery.

The study was scheduled for presentation Thursday at the
Multidisciplinary Head and Neck Cancer Symposium in Scottsdale,
Ariz.

"Historically, if you had a recurrence, you might as well get your affairs in order, because survival rates were so dismal," Fakhry said. "It was hard to say, 'Yes, you should go through surgery.'"

"But this study shows us that surgery may have a significant survival benefit, particularly in HPV-positive patients," she said.

It's not clear why patients with HPV-related mouth and throat
cancers are more likely to survive than those with HPV-negative
cancers, the researchers said, but it might be that HPV-related
cancers are less aggressive or respond better to chemotherapy or
radiation treatment.

Throat and mouth cancers were once linked primarily to heavy
smoking. Now they are more often caused by HPV, a sexually
transmitted virus. About 70 percent of mouth and throat cancers in
the United States are HPV-positive, according to the study.

Data and conclusions presented at meetings typically are
considered preliminary until published in a peer-reviewed medical
journal.

Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.